14.25
price down icon1.72%   -0.25
pre-market  Vorhandelsmarkt:  14.62   0.37   +2.60%
loading
Schlusskurs vom Vortag:
$14.50
Offen:
$13.715
24-Stunden-Volumen:
1.31M
Relative Volume:
0.77
Marktkapitalisierung:
$780.55M
Einnahmen:
$15.84M
Nettoeinkommen (Verlust:
$-308.48M
KGV:
-2.1991
EPS:
-6.48
Netto-Cashflow:
$-153.08M
1W Leistung:
+2.08%
1M Leistung:
+0.28%
6M Leistung:
-6.80%
1J Leistung:
+86.89%
1-Tages-Spanne:
Value
$13.61
$14.56
1-Wochen-Bereich:
Value
$13.55
$15.84
52-Wochen-Spanne:
Value
$4.45
$19.18

Uniqure N V Stock (QURE) Company Profile

Name
Firmenname
Uniqure N V
Name
Telefon
1-339-970-7000
Name
Adresse
PAASHEUVELWEG 25A, AMSTERDAM
Name
Mitarbeiter
209
Name
Twitter
@uniQure_NV
Name
Nächster Verdiensttermin
2024-07-30
Name
Neueste SEC-Einreichungen
Name
QURE's Discussions on Twitter

Vergleichen Sie QURE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
QURE
Uniqure N V
14.25 764.29M 15.84M -308.48M -153.08M -6.48
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Uniqure N V Stock (QURE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-01 Fortgesetzt Chardan Capital Markets Buy
2024-12-10 Hochstufung Raymond James Outperform → Strong Buy
2024-10-10 Fortgesetzt Raymond James Outperform
2024-02-29 Herabstufung Goldman Buy → Neutral
2023-12-19 Herabstufung Mizuho Buy → Neutral
2022-03-17 Hochstufung UBS Neutral → Buy
2021-06-15 Eingeleitet BTIG Research Buy
2021-05-21 Eingeleitet UBS Neutral
2021-04-26 Fortgesetzt Credit Suisse Outperform
2021-04-01 Hochstufung Mizuho Neutral → Buy
2021-01-07 Hochstufung Guggenheim Neutral → Buy
2020-11-24 Eingeleitet H.C. Wainwright Buy
2020-11-11 Eingeleitet Berenberg Buy
2020-11-09 Eingeleitet Jefferies Buy
2020-11-04 Eingeleitet Cantor Fitzgerald Overweight
2020-10-23 Eingeleitet RBC Capital Mkts Outperform
2020-08-25 Eingeleitet Raymond James Strong Buy
2020-07-31 Hochstufung Robert W. Baird Neutral → Outperform
2020-06-25 Herabstufung Mizuho Buy → Neutral
2020-06-25 Herabstufung Robert W. Baird Outperform → Neutral
2020-06-25 Herabstufung Wells Fargo Overweight → Equal Weight
2019-12-03 Eingeleitet Cowen Outperform
2019-12-03 Eingeleitet Goldman Buy
2019-11-05 Eingeleitet Credit Suisse Outperform
2019-10-11 Eingeleitet Stifel Buy
2019-09-25 Eingeleitet Bernstein Outperform
2019-09-12 Eingeleitet Mizuho Buy
2019-07-30 Herabstufung Guggenheim Buy → Neutral
2019-07-08 Bestätigt Cantor Fitzgerald Overweight
2019-04-12 Eingeleitet Piper Jaffray Overweight
2019-03-29 Eingeleitet Robert W. Baird Outperform
Alle ansehen

Uniqure N V Aktie (QURE) Neueste Nachrichten

pulisher
12:08 PM

uniQure N.V. Stock Analysis and ForecastFree Consultation - jammulinksnews.com

12:08 PM
pulisher
Jul 22, 2025

What drives uniQure N.V. stock priceExceptional trading performance - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Is uniQure N.V. a good long term investmentHigh-velocity gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

uniQure N.V. to Report Second Quarter 2025 Financial Results and Host Conference Call on July 29, 2025 - Nasdaq

Jul 22, 2025
pulisher
Jul 22, 2025

uniQure to Announce Second Quarter 2025 Financial Results - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

Gene Therapy Leader uniQure Schedules Q2 2025 Earnings: Key Details for Investors - Stock Titan

Jul 22, 2025
pulisher
Jul 20, 2025

What analysts say about uniQure N.V. stockHigh-yield market plays - Autocar Professional

Jul 20, 2025
pulisher
Jul 15, 2025

Why uniQure N.V. stock attracts strong analyst attentionReal Chart Play - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes uniQure N.V. stock price move sharplyHigh Reward Swing Trades - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

(QURE) Trading Advice - news.stocktradersdaily.com

Jul 11, 2025
pulisher
Jul 10, 2025

Stifel Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛

Jul 10, 2025
pulisher
Jul 03, 2025

uniQure N.V. (NASDAQ:QURE) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Jul 03, 2025
pulisher
Jun 30, 2025

(QURE) Technical Data - news.stocktradersdaily.com

Jun 30, 2025
pulisher
Jun 30, 2025

uniQure stock rating reiterated at Buy by Stifel ahead of key data - Investing.com

Jun 30, 2025
pulisher
Jun 25, 2025

Is uniQure NV overvalued or undervalued? - MarketsMojo

Jun 25, 2025
pulisher
Jun 24, 2025

uniQure N.V. director Balachandran Madhavan sells $30,518 in shares - Investing.com

Jun 24, 2025
pulisher
Jun 23, 2025

Lake Street: AMT-130 Could Be Game-Changer For ClearPoint - Insider Monkey

Jun 23, 2025
pulisher
Jun 22, 2025

11 Best Genomics Stocks to Buy According to Hedge Funds - Insider Monkey

Jun 22, 2025
pulisher
Jun 21, 2025

uniQure N.V. chief legal officer Potts sells $70k in shares By Investing.com - Investing.com South Africa

Jun 21, 2025
pulisher
Jun 17, 2025

uniQure: Price And Value Have Caught Up (NASDAQ:QURE) - Seeking Alpha

Jun 17, 2025
pulisher
Jun 16, 2025

Assenagon Asset Management S.A. Acquires 261,323 Shares of uniQure (NASDAQ:QURE) - Defense World

Jun 16, 2025
pulisher
Jun 14, 2025

uniQure shareholders approve executive compensation, board reappointments - Investing.com India

Jun 14, 2025
pulisher
Jun 13, 2025

uniQure shareholders approve executive compensation, board reappointments By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 11, 2025

uniQure (QURE) Appoints Kylie O'Keefe to Advance Global Strategy - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

uniQure appoints Kylie O’Keefe as Chief Customer and Strategy Officer By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

uniQure appoints Kylie O’Keefe as Chief Customer and Strategy Officer - Investing.com India

Jun 11, 2025
pulisher
Jun 11, 2025

uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy Officer - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

uniQure Prepares for Historic Huntington's Disease Treatment Launch with Key Executive Hire - Stock Titan

Jun 11, 2025
pulisher
Jun 09, 2025

Learn to Evaluate (QURE) using the Charts - news.stocktradersdaily.com

Jun 09, 2025
pulisher
Jun 06, 2025

uniQure (QURE) Positioned for Growth Amid Regulatory Changes - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

RFK Jr. looks to fast track rare disease drug approvals (updated) - Seeking Alpha

Jun 06, 2025
pulisher
Jun 06, 2025

Bank of America Corp DE Has $1.22 Million Stock Holdings in uniQure (NASDAQ:QURE) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Stock Traders Buy Large Volume of uniQure Call Options (NASDAQ:QURE) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

stifel reiterates buy rating on uniQure stock after CEO meeting By Investing.com - Investing.com UK

Jun 05, 2025
pulisher
Jun 05, 2025

uniQure (NASDAQ:QURE) Short Interest Update - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

H.C. Wainwright reaffirms Buy rating on uniQure stock after FDA meeting By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

H.C. Wainwright reaffirms Buy rating on uniQure stock after FDA meeting - Investing.com Australia

Jun 03, 2025

Finanzdaten der Uniqure N V-Aktie (QURE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):